Total Payments
$3,117
2024 Payments
$897.32
Companies
23
Transactions
100
Medicare Patients
20,057
Medicare Billing
$966,405
Payment Breakdown by Category
Food & Beverage$3,117 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,117 | 100 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $742.07 | 27 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $423.90 | 10 | $0 (2023) |
| GlaxoSmithKline, LLC. | $266.71 | 9 | $0 (2023) |
| Merck Sharp & Dohme LLC | $215.97 | 8 | $0 (2024) |
| Abbott Laboratories | $179.26 | 3 | $0 (2019) |
| ABBVIE INC. | $178.49 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $172.68 | 4 | $0 (2024) |
| Esperion Therapeutics, Inc. | $149.88 | 2 | $0 (2021) |
| HEARTFLOW, INC. | $140.43 | 1 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $123.83 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $897.32 | 30 | Novo Nordisk Inc ($563.68) |
| 2023 | $367.73 | 14 | Novo Nordisk Inc ($132.38) |
| 2022 | $300.75 | 15 | Boehringer Ingelheim Pharmaceuticals, Inc. ($125.79) |
| 2021 | $744.15 | 20 | Boehringer Ingelheim Pharmaceuticals, Inc. ($173.11) |
| 2020 | $155.21 | 3 | GlaxoSmithKline, LLC. ($131.92) |
| 2019 | $424.42 | 11 | Abbott Laboratories ($179.26) |
| 2018 | $202.83 | 6 | Merck Sharp & Dohme Corporation ($136.65) |
| 2017 | $24.26 | 1 | GlaxoSmithKline, LLC. ($24.26) |
All Payment Transactions
100 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: VACCINE | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $30.26 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Obesity | ||||||
| 11/14/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $26.10 | General |
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $124.83 | General |
| Category: Obesity | ||||||
| 10/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.35 | General |
| 10/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Obesity | ||||||
| 09/19/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Obesity | ||||||
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Respiratory | ||||||
| 08/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.42 | General |
| 08/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Biological | ||||||
| 07/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Obesity | ||||||
| 07/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.38 | General |
| 07/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Obesity | ||||||
| 06/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Oncology | ||||||
| 05/23/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $140.43 | General |
| Category: Coronary | ||||||
| 05/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Obesity | ||||||
| 05/01/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.40 | General |
| 04/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Obesity | ||||||
| 03/14/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Bone Health | ||||||
| 03/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Oncology | ||||||
| 03/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 42 | 5,094 | 5,879 | $1.0M | $239,785 |
| 2022 | 45 | 5,195 | 6,183 | $915,541 | $265,845 |
| 2021 | 48 | 5,021 | 5,852 | $762,444 | $236,059 |
| 2020 | 48 | 4,747 | 5,471 | $780,512 | $224,715 |
Total Patients
20,057
Total Services
23,385
Medicare Billing
$966,405
Procedure Codes
183
All Medicare Procedures & Services
183 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 314 | 575 | $237,680 | $60,929 | 25.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 299 | 299 | $183,885 | $44,113 | 24.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 356 | 356 | $140,620 | $30,876 | 22.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 43 | 43 | $47,415 | $12,126 | 25.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 149 | $42,640 | $10,819 | 25.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 50 | 50 | $39,500 | $9,535 | 24.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 102 | 102 | $28,560 | $7,657 | 26.8% |
| 82306 | Vitamin d-3 level | Office | 2023 | 237 | 246 | $27,825 | $7,103 | 25.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 340 | 358 | $26,915 | $5,863 | 21.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 398 | 635 | $20,575 | $5,318 | 25.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 346 | 397 | $24,985 | $5,166 | 20.7% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2023 | 19 | 19 | $19,285 | $4,804 | 24.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 98 | 98 | $8,915 | $3,490 | 39.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 264 | 279 | $42,680 | $3,406 | 8.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 286 | 298 | $13,150 | $3,080 | 23.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 334 | 381 | $12,995 | $2,891 | 22.2% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2023 | 94 | 94 | $29,170 | $2,816 | 9.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 78 | 78 | $7,410 | $2,806 | 37.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $9,305 | $2,293 | 24.6% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 127 | 149 | $10,430 | $2,201 | 21.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 211 | 229 | $10,790 | $2,190 | 20.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 15 | 15 | $6,000 | $1,962 | 32.7% |
| 82746 | Folic acid level, serum | Office | 2023 | 65 | 69 | $4,830 | $994.29 | 20.6% |
| 92567 | Test to assess middle ear function | Office | 2023 | 70 | 70 | $8,750 | $955.10 | 10.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 13 | 18 | $4,500 | $772.64 | 17.2% |
About Dr. Linda Tepper, MD
Dr. Linda Tepper, MD is a Internal Medicine healthcare provider based in Lake Success, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760419188.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Linda Tepper, MD has received a total of $3,117 in payments from pharmaceutical and medical device companies, with $897.32 received in 2024. These payments were reported across 100 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,117).
As a Medicare-enrolled provider, Tepper has provided services to 20,057 Medicare beneficiaries, totaling 23,385 services with total Medicare billing of $966,405. Data is available for 4 years (2020–2023), covering 183 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Lake Success, NY
- Active Since 06/28/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1760419188
Products in Payments
- Wegovy (Drug) $437.99
- JARDIANCE (Drug) $423.90
- FreeStyle Libre (Device) $179.26
- TRELEGY ELLIPTA (Drug) $148.44
- FFRct (Device) $140.43
- Ozempic (Drug) $127.50
- NEXLIZET (Drug) $125.00
- GENERAL THERAPIES (Device) $123.83
- ENTRESTO (Drug) $123.58
- JANUMET (Drug) $118.72
- NURTEC ODT (Drug) $87.80
- JANUVIA (Drug) $77.57
- Aimovig (Biological) $71.88
- ELIQUIS (Drug) $66.76
- UBRELVY (Drug) $65.76
- VRAYLAR (Drug) $54.36
- XIFAXAN (Drug) $53.41
- LEQVIO (Drug) $49.10
- SHINGRIX (Biological) $41.98
- AREXVY (Drug) $35.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lake Success
Francis Arena, Md, MD
Internal Medicine — Payments: $1.4M
Internal Medicine $1.4M
Dr. Bradley Morganstern, M.d, M.D
Internal Medicine — Payments: $80,254
Internal Medicine $80,254
Anna Kurzyna-Solinas, Md, MD
Internal Medicine — Payments: $8,761
Internal Medicine $8,761
Brian Feingold, Md, MD
Internal Medicine — Payments: $1,752
Internal Medicine $1,752
Dr. Mitchell Locke, Md, MD
Internal Medicine — Payments: $1,337
Internal Medicine $1,337
Henry Vuong, M.d, M.D
Internal Medicine — Payments: $1,223
Internal Medicine $1,223